Kanoski, S E <br/><br/>
Liraglutide, leptin and their combined effects on feeding: additive intake reduction through common intracellular signalling mechanisms.  [electronic resource] 

 -  Diabetes, obesity & metabolism  Mar 2015 
 - 285-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.12423  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Appetite Depressants--pharmacology<br/>Body Weight--drug effects<br/>Drug Therapy, Combination--methods<br/>Eating--drug effects<br/>Glucagon-Like Peptide 1--analogs & derivatives<br/>Hypothalamus--drug effects<br/>Incretins--pharmacology<br/>Leptin--pharmacology<br/>Liraglutide<br/>Male<br/>Obesity--drug therapy<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 1--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>STAT3 Transcription Factor--drug effects<br/>Weight Loss